cysteamine has been researched along with ifosfamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ishikawa, M; Sasaki, K; Takayanagi, Y | 1 |
| Ono, M; Satoh, T | 1 |
1 review(s) available for cysteamine and ifosfamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cysteamine and ifosfamide
| Article | Year |
|---|---|
Influence of buthionine sulfoximine on the lethality of ifosfamide and ifosfamide-induced urotoxicity in mice.
Topics: Animals; Buthionine Sulfoximine; Cysteamine; Glutathione; Ifosfamide; Liver; Male; Methionine Sulfoximine; Mice; Organ Size; Urinary Bladder; Urologic Diseases | 1989 |
Pharmacological studies on lappaconitine: antinociception and inhibition of the spinal action of substance P and somatostatin.
Topics: Aconitine; Analgesics; Animals; Behavior, Animal; Brain; Cysteamine; Diclofenac; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred Strains; Morphine; Neurons; Nociceptors; Somatostatin; Spinal Cord; Substance P | 1991 |